Cargando…
Effect of Chelation Therapy on a Korean Patient With Brain Manganese Deposition Resulting From a Compound Heterozygous Mutation in the SLC39A14 Gene
Mutations in the manganese transporter gene SLC39A14 lead to inherited disorders of manganese metabolism. Chelation therapy with edetate calcium disodium (SLC39A14 deficiencyTA) is known to effectively reduce manganese deposition. We describe the first identified Korean case of SLC39A14-associated m...
Autores principales: | Lee, Jae-Hyeok, Shin, Jin-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Movement Disorder Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171315/ https://www.ncbi.nlm.nih.gov/pubmed/35306789 http://dx.doi.org/10.14802/jmd.21143 |
Ejemplares similares
-
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
por: Tuschl, Karin, et al.
Publicado: (2016) -
Loss of slc39a14 causes simultaneous manganese hypersensitivity and deficiency in zebrafish
por: Tuschl, Karin, et al.
Publicado: (2022) -
Manganese transporter Slc39a14 deficiency revealed its key role in maintaining manganese homeostasis in mice
por: Xin, Yongjuan, et al.
Publicado: (2017) -
Hypermanganesemia due to mutations in SLC39A14: further insights into Mn deposition in the central nervous system
por: Marti-Sanchez, L., et al.
Publicado: (2018) -
Functional analysis of SLC39A8 mutations and their implications for manganese deficiency and mitochondrial disorders
por: Choi, Eun-Kyung, et al.
Publicado: (2018)